AfoliOpen Afoli →

Teriparatide

Teriparatide is an approved active ingredient.

Open in Afoli Medicines →

Pharmaceutical drug

Informational only — not medical advice. Ask a doctor or pharmacist; never change a dose on your own.

What it is used for

BONSITY is indicated: For the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have failed or are intolerant to other available osteoporosis therapy.

US label

Teriparatide SUN is indicated in adults. Treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture.

EMA

How it works

Common side effects

The following clinically significant adverse reactions are described elsewhere in the labeling: Hypersensitivity Reactions Osteosarcoma Hypercalcemia and Cutaneous Calcification Risk of Urolithiasis Orthostatic Hypotension Risk of Digoxin Toxicity Most common adverse reactions (>10%) include: arthralgia, pain, and…

US label

Who should not take it

BONSITY is contraindicated in patients with a history of severe hypersensitivity to teriparatide or any of the inactive ingredients of BONSITY. Reactions have included anaphylaxis and angioedema.

US label

Pregnancy and breastfeeding

There are no available data on BONSITY use in pregnant women to evaluate for drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.

Excerpts from the US prescribing label (public domain), copied without changes.

Interactions

Recorded interactions from open sources (Wikidata, US labels). The list is not complete — ask a pharmacist.

Brand names

United States

Bonsity

European Union

Forsteo · Kauliv · Livogiva · Movymia · Sondelbay · Teriparatide Sun · Terrosa · Zandoriah

Canada

Apo-Teriparatide · Osnuvo · Teva-Teriparatide

Other trade names

Qutavina

Approval status

US Food and Drug Administration
prescription · since 2002
European Medicines Agency
authorised · since 2003
Health Canada
prescription · marketed
First approval anywhere
2002

Codes

ATC
H05AA02
RxNorm CUI
32915
ChEMBL
CHEMBL525610
PubChem CID
132274287
Wikidata
Q411781

Frequently asked questions

What is Teriparatide used for?

Teriparatide is used for: Bone fracture, Postmenopausal osteoporosis, Osteoarthritis susceptibility 1, Bone disease, Osteoporosis, and Hypoparathyroidism.

What are the brand names of Teriparatide?

Brand names of Teriparatide include Bonsity, Forsteo, Kauliv, Livogiva, Movymia, Sondelbay, Teriparatide Sun, and Terrosa.

Sources and licences

Updated November 15, 2026